Invesaro

Stocks WST Earnings

Earnings

West Pharmaceutical Services Inc (WST) earnings

Quarterly results of West Pharmaceutical Services Inc as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when WST files with the SEC.

Next earnings date

West Pharmaceutical Services Inc is expected to report around October 22, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) West Pharmaceutical Services Inc reported revenue of $872.3M (+13.8% on the same quarter a year earlier) and net income of $154M (+16.8% on the same quarter a year earlier).

Diluted earnings per share were $2.15 (+18.1% on the same quarter a year earlier).

Filed with the SEC on July 23, 2026.

Revenue by quarter
Q3 24: $746.9M $746.9M Q3 24Q4 24: $748.8M $748.8M Q4 24Q1 25: $698M $698M Q1 25Q2 25: $766.5M $766.5M Q2 25Q3 25: $804.6M $804.6M Q3 25Q4 25: $805M $805M Q4 25Q1 26: $844.9M $844.9M Q1 26Q2 26: $872.3M $872.3M Q2 26
Net income by quarter
Q3 24: $136M $136M Q3 24Q4 24: $130.1M $130.1M Q4 24Q1 25: $89.8M $89.8M Q1 25Q2 25: $131.8M $131.8M Q2 25Q3 25: $140M $140M Q3 25Q4 25: $132.1M $132.1M Q4 25Q1 26: $138.8M $138.8M Q1 26Q2 26: $154M $154M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$872.3M+13.8%$154M$2.15
Q1 FY2026March 31, 2026$844.9M+21%$138.8M$1.92
Q4 FY2025December 31, 2025$805M+7.5%$132.1M-
Q3 FY2025September 30, 2025$804.6M+7.7%$140M$1.92
Q2 FY2025June 30, 2025$766.5M-$131.8M$1.82
Q1 FY2025March 31, 2025$698M-$89.8M$1.23
Q4 FY2024December 31, 2024$748.8M-$130.1M-
Q3 FY2024September 30, 2024$746.9M-$136M$1.85

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is West Pharmaceutical Services Inc's next earnings date?

West Pharmaceutical Services Inc is expected to report around October 22, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were West Pharmaceutical Services Inc's latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, West Pharmaceutical Services Inc reported revenue of $872.3M and net income of $154M (+16.8% on the same quarter a year earlier). The figures come from its filing with the SEC.

Is West Pharmaceutical Services Inc's revenue growing?

Revenue in Q2 FY2026 was $872.3M, up 13.8% from $766.5M in the same quarter a year earlier.

Get an email when WST reports

Follow WST and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when WST files with the SEC.

Source: quarterly figures West Pharmaceutical Services Inc tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about West Pharmaceutical Services Inc